You just read:

Nordic Nanovector: Updated Results From Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH in December

News provided by

Nordic Nanovector

Nov 01, 2017, 09:29 ET